Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Condition(s):Adenocarcinoma of the Prostate; Hormone-refractory Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate CancerLast Updated:June 23, 2014Completed